GENB Generate Biomedicines, Inc. - Common Stock
$12,50
Harga · Mei 20, 2026
Fundamental per Mei 7, 2026
Rentang 52M
$11–$17
25% of range
Peringkat Analis
BUY
11 analysts
Target Harga
$25
+103% upside
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
GENB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$12.50
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$11 – $17
GENB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
GENB
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
GENB
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
GENB
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
GENB
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
GENB
Median Rekan
GENB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
11 analis
- Beli Kuat 2 18,2%
- Beli 8 72,7%
- Tahan 1 9,1%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
5 analis · 2026-05-18
Median
$25.00
← Di bawah semua target
$12.50
Rendah
$22.00
Tinggi
$30.00
Target median
$25.00
+100,0%
Target rata-rata
$25.40
+103,2%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.55%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-1.06 | $-0.51 | -0.55% |
Perbandingan Sejawat Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| GENB | — | — | — | — | — | — |
| SION | $1.84B | -21.9 | — | — | -23.4% | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 15
| Metrik | Tren | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $7M | $9M | |
| R&D Expense | $58M | $47M | |
| SG&A Expense | $14M | $10M | |
| Operating Expenses | $71M | $57M | |
| Operating Income | $-64M | $-48M | |
| Interest Income | $3M | $4M | |
| Other Non-op | $2M | $4M | |
| Pretax Income | $-62M | $-44M | |
| Income Tax | $28.0K | $56.0K | |
| Net Income | $-61M | $-42M | |
| EPS (Basic) | $-1.07 | $-1.62 | |
| EPS (Diluted) | $-1.07 | $-1.62 | |
| Shares (Basic) | 64,871,295 | 32,791,905 | |
| Shares (Diluted) | 64,871,295 | 32,791,905 | |
| EBITDA | $-64M | · |
Neraca 20
| Metrik | Tren | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $161M | · | |
| Short-term Investments | $356M | · | |
| Prepaid Expense | $19M | · | |
| Current Assets | $535M | · | |
| PP&E (Net) | $28M | · | |
| PP&E (Gross) | $79M | · | |
| Accum. Depreciation | $52M | · | |
| Other Non-current Assets | $5M | · | |
| Total Assets | $626M | · | |
| Accounts Payable | $8M | · | |
| Current Liabilities | $58M | · | |
| Capital Leases | $49M | · | |
| Other Non-current Liabilities | $0 | · | |
| Total Liabilities | $111M | · | |
| Common Stock | $128.0K | · | |
| Retained Earnings | $-738M | · | |
| AOCI | $24.0K | · | |
| Stockholders' Equity | $515M | · | |
| Liabilities + Equity | $626M | · | |
| Shares Outstanding | 128,192,484 | · |
Arus Kas 8
| Metrik | Tren | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $3M | $3M | |
| Stock-based Comp | $6M | $5M | |
| Operating Cash Flow | $-80M | $-53M | |
| CapEx | $4M | $751.0K | |
| Investing Cash Flow | $-260M | $76M | |
| Financing Cash Flow | $379M | $21M | |
| Net Change in Cash | $39M | $43M | |
| Free Cash Flow | $-84M | · |
Profitabilitas 7
| Metrik | Tren | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -887.5% | · | |
| Net Margin | -850.6% | · | |
| Pretax Margin | -853.9% | · | |
| EBITDA Margin | -887.5% | · | |
| ROA | -19.6% | · | |
| ROE | -23.9% | · | |
| ROIC | -12.5% | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 9.2 | · | |
| Quick Ratio | 8.8 | · |
Efisiensi 1
| Metrik | Tren | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.